BioCentury
ARTICLE | Company News

Vysis licenses disputed patent to bioMerieux

July 10, 2001 7:00 AM UTC

bioMerieux received a license to VYSI's U.S. Patent No. 5,750,338, which covers a method intended to improve clinical sensitivity of enzyme amplification technologies. The Collins patent is the subjec...